Combined Alcohol-Depression Screens; Alzheimer Infection Prize

— News and commentary from the psychiatry world

The FDA approved sublingual film formulations of buprenorphine/naloxone -- as branded (Cassipa) and generic products -- at a new dosage of 16 mg buprenorphine/4 mg naloxone and indicated as maintenance treatment for opioid dependence.

Primary care providers should screen patients for alcohol abuse and depression at the same time, a group of researchers suggested. "Our study provides evidence that, with a simple questionnaire, primary care doctors have a big opportunity to better spot depressive symptoms in at-risk patients and help improve their lives through treatment," said lead author Matthew Hirschtritt, MD, of the University of California San Francisco, in a statement. (Journal of the American Board of Family Medicine)

ADHD may increase risk of developing Parkinson's and other similar diseases -- especially for those prescribed psychostimulants, who saw an 8.6-fold increased risk for basal ganglia and cerebellum diseases in young and mid-adulthood. (Neuropsychopharmacology)

Positive psychological well-being was beneficial to peoples' hearts, including a reduced risk for cardiovascular disease. "It may seem challenging to help patients modify psychological well-being in the face of a new medical diagnosis, but these events can represent a 'teachable moment,'" said Darwin Labarthe, MD, PhD, of the Northwestern University Feinberg School of Medicine, in a statement. (Journal of the American College of Cardiology)

Similar genetic variability may link autism spectrum disorder with schizophrenia. Researchers of this new study said they're planning to investigate a similar overlapping copy number variations in bipolar disorder. (Cell Reports)

Accessibility Statement

At MedPage Today, we are committed to ensuring that individuals with disabilities can access all of the content offered by MedPage Today through our website and other properties. If you are having trouble accessing www.medpagetoday.com, MedPageToday's mobile apps, please email legal@ziffdavis.com for assistance. Please put "ADA Inquiry" in the subject line of your email.